Kuros Biosciences Ltd (CSBTF)
9.05
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Kuros Biosciences Total Assets (Quarterly): 85.08M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 85.08M |
| June 30, 2023 | 87.02M |
| June 30, 2023 | 87.02M |
| December 31, 2022 | 89.46M |
| June 30, 2022 | 92.49M |
| June 30, 2022 | 92.49M |
| December 31, 2021 | 99.92M |
| June 30, 2021 | 101.51M |
| June 30, 2021 | 101.51M |
| December 31, 2020 | 108.01M |
| June 30, 2020 | 84.98M |
| June 30, 2020 | 84.98M |
| December 31, 2019 | 90.67M |
| June 30, 2019 | 83.05M |
| June 30, 2019 | 83.05M |
| December 31, 2018 | 87.17M |
| June 30, 2018 | 79.15M |
| June 30, 2018 | 79.15M |
| December 31, 2017 | 88.37M |
| June 30, 2017 | 95.12M |
| June 30, 2017 | 95.12M |
| December 31, 2016 | 43.01M |
| June 30, 2016 | 49.67M |
| June 30, 2016 | 49.67M |
| Date | Value |
|---|---|
| December 31, 2015 | 16.38M |
| June 30, 2015 | 3.116M |
| June 30, 2015 | 3.116M |
| December 31, 2014 | 17.83M |
| June 30, 2014 | 21.76M |
| June 30, 2014 | 21.76M |
| December 31, 2013 | 45.64M |
| September 30, 2013 | 18.52M |
| June 30, 2013 | 20.82M |
| June 30, 2013 | 20.82M |
| March 31, 2013 | 26.67M |
| December 31, 2012 | 33.29M |
| September 30, 2012 | 38.19M |
| June 30, 2012 | 39.21M |
| March 31, 2012 | 10.26M |
| December 31, 2011 | 32.71M |
| September 30, 2011 | 43.19M |
| June 30, 2011 | 51.76M |
| March 31, 2011 | 52.83M |
| December 31, 2010 | 57.85M |
| September 30, 2010 | 61.02M |
| June 30, 2010 | 59.49M |
| March 31, 2010 | 53.60M |
| December 31, 2009 | 66.34M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
83.05M
Minimum
Jun 2019
108.01M
Maximum
Dec 2020
91.42M
Average
89.46M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| AC Immune SA | 217.65M |
| CRISPR Therapeutics AG | 2.230B |
| Addex Therapeutics Ltd | 5.526M |
| NLS Pharmaceutics Ltd | 2.270M |
| Molecular Partners AG | 236.15M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 17.56M |
| Shareholders Equity (Quarterly) | 67.52M |
| Current Ratio | 2.062 |